These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23863057)

  • 21. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study.
    Armstrong PW;
    Eur Heart J; 2006 Jul; 27(13):1530-8. PubMed ID: 16757491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 23. Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study).
    Welsh RC; Van de Werf F; Westerhout CM; Goldstein P; Gershlick AH; Wilcox RG; Danays T; Bluhmki E; Lopes RD; Steg PG; Armstrong PW
    Am J Cardiol; 2014 Sep; 114(6):811-9. PubMed ID: 25108302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reperfusion for ST-segment elevation myocardial infarction: an overview of current treatment options.
    Van De Werf F; Baim DS
    Circulation; 2002 Jun; 105(24):2813-6. PubMed ID: 12070105
    [No Abstract]   [Full Text] [Related]  

  • 25. The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study.
    Armstrong PW; Gershlick A; Goldstein P; Wilcox R; Danays T; Bluhmki E; Van de Werf F;
    Am Heart J; 2010 Jul; 160(1):30-35.e1. PubMed ID: 20598969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results from clinical trials on ST-elevation myocardial infarction in a historic perspective with some pathophysiological aspects.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2003 Dec; 37(6):316-23. PubMed ID: 14668180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of acute myocardial infarction: What remains of intravenous thrombolysis?].
    Bonnet JL; Bonnet G
    Presse Med; 2011 Jun; 40(6):611-4. PubMed ID: 21570245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacological reperfusion in acute myocardial infarct].
    Lorenzoni R; Gensini GF; De Caterina R
    G Ital Cardiol; 1998 Dec; 28(12):1441-55. PubMed ID: 9887401
    [No Abstract]   [Full Text] [Related]  

  • 29. Drip-and-ship for acute ST-segment myocardial infarction: the pharmacoinvasive strategy for patients treated with fibrinolytic therapy.
    Goodman SG; Cantor WJ
    Pol Arch Med Wewn; 2009 Nov; 119(11):726-30. PubMed ID: 19920797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunctive therapies in the cath lab. Combination of tirofiban and alteplase in acute myocardial infarction.
    Arjomand H; Sokil AB; Arjmand R; Fischer HA; Wolf NM
    J Invasive Cardiol; 2001 Sep; 13(9):647-50. PubMed ID: 11533504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological facilitation of coronary intervention in ST-segment elevation myocardial infarction: time is of the essence.
    Gersh BJ; Stone GW
    JACC Cardiovasc Interv; 2010 Dec; 3(12):1292-4. PubMed ID: 21232724
    [No Abstract]   [Full Text] [Related]  

  • 33. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis.
    Borgia F; Goodman SG; Halvorsen S; Cantor WJ; Piscione F; Le May MR; Fernández-Avilés F; Sánchez PL; Dimopoulos K; Scheller B; Armstrong PW; Di Mario C
    Eur Heart J; 2010 Sep; 31(17):2156-69. PubMed ID: 20601393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic agents in coronary artery disease.
    Cairns JA; Hirsh J; Lewis HD; Resnekov L; Théroux P
    Chest; 1992 Oct; 102(4 Suppl):456S-481S. PubMed ID: 1395829
    [No Abstract]   [Full Text] [Related]  

  • 35. Facilitated percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction: comparison of prehospital tirofiban versus fibrinolysis before direct PCI.
    Möckel M; Bocksch W; Strohm S; Kühnle Y; Vollert J; Nibbe L; Dietz R
    Int J Cardiol; 2005 Aug; 103(2):193-200. PubMed ID: 16080980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
    Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
    Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing times in the treatment of myocardial infarction.
    Leitch JW
    Med J Aust; 2003 Apr; 178(8):367-8. PubMed ID: 12697006
    [No Abstract]   [Full Text] [Related]  

  • 38. The impact of place of enrollment and delay to reperfusion on 90-day post-infarction mortality in the ASSENT-4 PCI trial: assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention.
    Ross AM; Huber K; Zeymer U; Armstrong PW; Granger CB; Goldstein P; Bogaerts K; Van de Werf F
    JACC Cardiovasc Interv; 2009 Oct; 2(10):925-30. PubMed ID: 19850250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect?
    Brener SJ
    J Am Coll Cardiol; 2009 May; 53(18):1674-6. PubMed ID: 19406343
    [No Abstract]   [Full Text] [Related]  

  • 40. Personal reflections on fibrinolytic therapy of acute myocardial infarction.
    Braunwald E
    J Thromb Haemost; 2006 Mar; 4(3):684-5. PubMed ID: 16460456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.